A national education program for pharmacists funded by the Australian Government under the Quality Use of Diagnostics, Therapeutics and Pathology program.[/caption]
While the evidence bases for both CMs and Schedule 3 sleep aids are unlikely to immediately change, a core practice consideration is the risk-benefit profile of the respective non-prescription sleep aids for the individual patient. 
Is it really insomnia?
Knowledge to practice 
How pharmacists can support women with gestational diabetes
How pharmacists can use their pharmacotherapy medication management expertise to support women with gestational diabetes.
2019: A watershed year for Australian medicine safety
I am enormously proud of how our work has contributed to medicine safety and the quality use of medicines finally receiving the attention it warrants.
Federal election health platforms
Last week, several pledges were made by the Coalition and the Opposition that will impact health care around the nation.
The Coalition issued a statement...
Collaborate for RA patient benefits
Achieving better outcomes for rheumatoid arthritis patients requires successful collaboration between specialists, GPs and pharmacists.
A new NPS MedicineWise education program has highlighted the importance...
Allergic rhinitis management
Are you aware that untreated allergic rhinitis (AR) can result in impaired driving performance similar to a blood alcohol level of 0.5% due to...
